Endostar overcomes Osimertinib-resistance mediated EGFR-activation mutation, T790M and cis-C797S triple mutations via enhancing the binding of Osimertinib to EGFR protein

Life Sciences 2026

View at publisher

Authors: Zhongquan Song, Yanmei Zhu, Surong Fang, Shuhua Han

DOI: 10.1016/j.lfs.2026.124218

Cited by: 0

References: 33

Fields of Study & Subjects

Lung Cancer Treatments and Mutations HER2/EGFR in Cancer Research Cancer Genomics and Diagnostics

References 33